Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Sarah Parker

Concepts (350)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antimicrobial Stewardship
11
2021
136
4.430
Why?
Hospitals, Pediatric
22
2022
561
3.470
Why?
Anti-Infective Agents
12
2021
234
3.350
Why?
Anti-Bacterial Agents
35
2026
1935
3.000
Why?
Osteomyelitis
10
2026
146
2.220
Why?
Bacteremia
4
2025
218
2.090
Why?
Arthritis, Infectious
8
2026
77
2.080
Why?
Drug Utilization Review
6
2020
60
1.550
Why?
Bacterial Infections
7
2025
246
1.390
Why?
Blood Culture
4
2025
27
1.370
Why?
Metronidazole
3
2019
20
1.180
Why?
Staphylococcal Infections
6
2026
396
1.160
Why?
Appendicitis
3
2019
150
1.060
Why?
Child
51
2026
22638
1.020
Why?
Otitis Media
4
2024
178
0.990
Why?
Acute Disease
8
2025
1033
0.910
Why?
Methicillin-Resistant Staphylococcus aureus
4
2026
253
0.870
Why?
Kingella kingae
2
2022
12
0.840
Why?
Intensive Care Units, Neonatal
2
2025
295
0.820
Why?
Respiration, Artificial
3
2026
711
0.800
Why?
Retrospective Studies
27
2025
17291
0.700
Why?
Musculoskeletal System
1
2022
53
0.680
Why?
Musculoskeletal Diseases
2
2025
94
0.660
Why?
Surgical Wound Infection
2
2022
331
0.630
Why?
Humans
77
2026
145625
0.580
Why?
Infant
23
2026
10093
0.580
Why?
Microbial Sensitivity Tests
6
2026
367
0.560
Why?
Respiratory Tract Infections
1
2022
399
0.530
Why?
Interdisciplinary Communication
1
2019
200
0.530
Why?
Drug Resistance, Bacterial
3
2021
185
0.530
Why?
Medical Order Entry Systems
1
2018
40
0.520
Why?
Child, Preschool
20
2026
11888
0.520
Why?
Cefoxitin
1
2017
8
0.510
Why?
Gram-Negative Bacterial Infections
1
2017
50
0.500
Why?
Cephalosporins
2
2015
45
0.500
Why?
Ceftriaxone
1
2017
21
0.500
Why?
beta-Lactams
1
2017
32
0.490
Why?
Gram-Positive Bacterial Infections
1
2017
72
0.490
Why?
Interprofessional Relations
1
2019
274
0.480
Why?
Prescriptions
1
2016
74
0.480
Why?
Pneumonia, Bacterial
1
2017
114
0.480
Why?
Drug Costs
1
2017
115
0.480
Why?
Pyomyositis
3
2022
15
0.470
Why?
Communicable Diseases
4
2021
165
0.460
Why?
Exanthema
1
2016
86
0.450
Why?
Neutropenia
1
2016
153
0.450
Why?
Diarrhea
1
2016
190
0.440
Why?
Mycobacterium tuberculosis
4
2021
325
0.430
Why?
Thimerosal
2
2005
6
0.430
Why?
Health Resources
1
2016
130
0.420
Why?
Inpatients
4
2021
538
0.420
Why?
Preservatives, Pharmaceutical
2
2005
28
0.420
Why?
Enterovirus D, Human
1
2016
89
0.420
Why?
Disease Outbreaks
2
2021
420
0.400
Why?
Decision Support Systems, Clinical
1
2018
277
0.400
Why?
Enterovirus Infections
1
2016
175
0.390
Why?
Cephalexin
2
2024
14
0.380
Why?
Electronic Health Records
2
2019
1208
0.380
Why?
Guideline Adherence
1
2017
585
0.370
Why?
Inappropriate Prescribing
1
2013
66
0.370
Why?
Pandemics
2
2022
1700
0.370
Why?
Cross Infection
3
2025
258
0.360
Why?
Trachea
2
2026
253
0.360
Why?
Intensive Care Units, Pediatric
3
2025
293
0.330
Why?
Health Personnel
1
2018
750
0.330
Why?
Referral and Consultation
1
2017
878
0.320
Why?
Vancomycin
2
2023
96
0.320
Why?
Liver Abscess, Amebic
2
2009
3
0.310
Why?
Phospholipases A
2
2007
97
0.300
Why?
Urinary Tract Infections
2
2025
207
0.300
Why?
Male
29
2026
73014
0.300
Why?
Practice Guidelines as Topic
1
2017
1581
0.290
Why?
Stomach Rupture
1
2009
3
0.290
Why?
Phospholipases
1
2009
14
0.290
Why?
Thiolester Hydrolases
1
2009
13
0.290
Why?
Pericardial Effusion
1
2009
22
0.290
Why?
Lactones
1
2009
59
0.280
Why?
Peritonitis
1
2009
82
0.270
Why?
Staphylococcus aureus
5
2024
458
0.270
Why?
Pleural Effusion
1
2009
59
0.270
Why?
Diphtheria-Tetanus-Pertussis Vaccine
2
2005
28
0.270
Why?
Colorado
4
2020
4588
0.270
Why?
Drug Utilization
3
2017
170
0.270
Why?
Female
26
2026
79080
0.260
Why?
Cefadroxil
2
2024
8
0.250
Why?
Carboxylic Ester Hydrolases
1
2007
24
0.250
Why?
Gene Expression Regulation, Bacterial
2
2009
337
0.250
Why?
Cost Savings
2
2017
85
0.250
Why?
Adolescent
16
2026
22451
0.250
Why?
Time Factors
4
2024
7079
0.240
Why?
Dermatomycoses
1
2006
8
0.240
Why?
Infant, Newborn
7
2025
6449
0.230
Why?
Mycobacterium
1
2007
101
0.230
Why?
Pharmacy Service, Hospital
2
2017
90
0.230
Why?
Drug Approval
1
2006
93
0.230
Why?
Immunoglobulins, Intravenous
1
2006
134
0.220
Why?
Infection Control
3
2015
174
0.220
Why?
Intellectual Property
1
2005
7
0.220
Why?
Autistic Disorder
2
2005
215
0.210
Why?
Measles
1
2025
46
0.210
Why?
Specimen Handling
1
2026
178
0.210
Why?
Mycoses
1
2025
86
0.210
Why?
Simplexvirus
1
2004
80
0.210
Why?
Encephalitis, Viral
1
2004
45
0.210
Why?
Limbus Corneae
1
2023
8
0.200
Why?
Amoxicillin
1
2024
35
0.200
Why?
Bacterial Proteins
2
2018
976
0.200
Why?
Marijuana Abuse
1
2026
215
0.200
Why?
Herpes Simplex
1
2004
102
0.200
Why?
Lymphadenitis
1
2023
6
0.190
Why?
Drug Administration Schedule
3
2017
782
0.190
Why?
Hospitalization
5
2023
2468
0.190
Why?
Drainage
2
2017
187
0.180
Why?
Cisplatin
1
2024
346
0.180
Why?
Exosomes
1
2023
103
0.180
Why?
Extracellular Vesicles
1
2025
175
0.180
Why?
Databases, Factual
4
2025
1481
0.180
Why?
Exudates and Transudates
1
2021
12
0.180
Why?
Machine Learning
2
2025
590
0.170
Why?
Cross-Over Studies
1
2024
612
0.170
Why?
Fluoroquinolones
1
2021
44
0.170
Why?
Immunotherapy
1
2006
669
0.170
Why?
Risk Adjustment
1
2021
83
0.170
Why?
Fever
2
2017
320
0.160
Why?
Mucocutaneous Lymph Node Syndrome
1
2021
94
0.160
Why?
Antibiotic Prophylaxis
1
2022
133
0.160
Why?
Hospitals
3
2021
730
0.160
Why?
Bone Diseases, Infectious
1
2020
8
0.160
Why?
Delayed Diagnosis
1
2021
102
0.160
Why?
Treatment Outcome
7
2024
11744
0.160
Why?
Meningitis
1
2021
80
0.160
Why?
Laboratories
1
2021
109
0.150
Why?
Molecular Diagnostic Techniques
2
2020
104
0.150
Why?
Bacteroides fragilis
1
2019
14
0.150
Why?
Encephalitis
1
2021
142
0.150
Why?
Appendectomy
2
2017
91
0.150
Why?
Monte Carlo Method
1
2019
150
0.140
Why?
Drug Resistance, Neoplasm
1
2024
889
0.140
Why?
Autophagy
1
2021
290
0.140
Why?
Neisseriaceae Infections
1
2018
6
0.140
Why?
Pediatrics
3
2017
1122
0.140
Why?
Antibodies, Monoclonal
1
2006
1511
0.140
Why?
Entamoeba histolytica
2
2009
9
0.140
Why?
Area Under Curve
1
2019
333
0.140
Why?
Hospital Records
1
2018
10
0.140
Why?
Reactive Oxygen Species
1
2021
610
0.140
Why?
Drug Therapy, Combination
2
2021
1034
0.140
Why?
Proteomics
1
2025
1202
0.130
Why?
Induced Pluripotent Stem Cells
1
2021
269
0.130
Why?
Medical Records Systems, Computerized
1
2018
94
0.130
Why?
Hydrolysis
2
2009
195
0.130
Why?
Tuberculosis
1
2021
289
0.130
Why?
Sequence Homology, Amino Acid
2
2009
382
0.130
Why?
Combined Modality Therapy
2
2017
1269
0.130
Why?
United States
10
2026
16041
0.130
Why?
Patient Readmission
3
2017
771
0.130
Why?
MicroRNAs
1
2023
695
0.130
Why?
Abdominal Abscess
1
2017
28
0.120
Why?
Abscess
1
2017
77
0.120
Why?
Central Venous Catheters
1
2017
53
0.120
Why?
Medical Records
1
2017
190
0.120
Why?
Administration, Oral
2
2016
867
0.120
Why?
Drug Substitution
1
2017
62
0.120
Why?
Communicable Disease Control
1
2017
88
0.120
Why?
Drug Resistance
1
2017
145
0.120
Why?
Amino Acid Sequence
4
2009
2088
0.120
Why?
Drug Prescriptions
1
2018
290
0.120
Why?
Osteoarthritis
1
2018
204
0.120
Why?
Pharmacists
1
2019
260
0.120
Why?
Molecular Sequence Data
4
2009
2835
0.120
Why?
Rural Population
1
2021
673
0.110
Why?
Sensitivity and Specificity
3
2025
1992
0.110
Why?
Aftercare
1
2017
221
0.110
Why?
Administration, Intravenous
1
2016
172
0.110
Why?
Cell Wall
2
2021
60
0.110
Why?
Length of Stay
2
2020
1342
0.110
Why?
Community-Acquired Infections
1
2017
179
0.110
Why?
Knowledge Management
1
2014
2
0.110
Why?
Radiography
1
2017
856
0.110
Why?
Diabetes Mellitus
1
2023
1101
0.110
Why?
Clostridium Infections
1
2015
73
0.110
Why?
Prospective Studies
3
2024
8087
0.100
Why?
Medication Therapy Management
1
2014
73
0.100
Why?
Cost-Benefit Analysis
1
2017
632
0.100
Why?
Postoperative Care
1
2016
292
0.100
Why?
Antitubercular Agents
2
2021
211
0.100
Why?
Acute Kidney Injury
1
2021
861
0.100
Why?
Antineoplastic Agents
1
2024
2218
0.100
Why?
Tomography, X-Ray Computed
3
2009
2766
0.090
Why?
Drug Monitoring
1
2016
399
0.090
Why?
Bacteria
3
2023
766
0.090
Why?
Young Adult
5
2026
14240
0.090
Why?
Quality of Health Care
1
2017
692
0.090
Why?
Ambulatory Care
1
2017
627
0.090
Why?
Genotype
3
2021
1866
0.090
Why?
Laparoscopy
1
2017
474
0.090
Why?
Risk Assessment
2
2016
3678
0.090
Why?
Drug Hypersensitivity
1
2013
93
0.090
Why?
Physicians
1
2019
954
0.080
Why?
Cohort Studies
2
2017
6045
0.070
Why?
Patient Education as Topic
1
2014
769
0.070
Why?
Paromomycin
1
2009
3
0.070
Why?
Trophozoites
1
2009
3
0.070
Why?
Mycolic Acids
1
2009
6
0.070
Why?
Antiprotozoal Agents
1
2009
15
0.070
Why?
Practice Patterns, Physicians'
1
2018
1370
0.070
Why?
Attitude of Health Personnel
1
2017
1212
0.070
Why?
DNA, Protozoan
1
2008
32
0.070
Why?
Dose-Response Relationship, Drug
2
2017
2018
0.070
Why?
Tuberculosis, Pulmonary
1
2009
127
0.070
Why?
Nitrobenzenes
1
2007
15
0.060
Why?
Chromatography, Thin Layer
1
2007
24
0.060
Why?
Polysorbates
1
2007
42
0.060
Why?
Adult
6
2026
40821
0.060
Why?
Cell Line, Tumor
2
2025
3538
0.060
Why?
Terminology as Topic
1
2009
253
0.060
Why?
Injections, Intravenous
2
2017
197
0.060
Why?
Gentian Violet
1
2026
4
0.060
Why?
Membrane Lipids
1
2007
81
0.060
Why?
Phenazines
1
2026
17
0.060
Why?
Animals
6
2024
38030
0.060
Why?
Maximum Tolerated Dose
1
2006
216
0.060
Why?
Selection, Genetic
1
2008
269
0.060
Why?
Recombinant Proteins
1
2009
1361
0.060
Why?
Measles Vaccine
1
2025
19
0.060
Why?
Enzyme Inhibitors
1
2009
820
0.060
Why?
United States Food and Drug Administration
1
2006
207
0.060
Why?
Aminopeptidases
1
2024
20
0.050
Why?
Ethylmercury Compounds
1
2004
1
0.050
Why?
Diphtheria-Tetanus Vaccine
1
2004
5
0.050
Why?
Risk Factors
2
2016
10840
0.050
Why?
Methylmercury Compounds
1
2004
9
0.050
Why?
Mass Spectrometry
2
2025
728
0.050
Why?
Drug Industry
1
2005
46
0.050
Why?
Motivational Interviewing
1
2026
121
0.050
Why?
Aphasia
1
2004
24
0.050
Why?
Escherichia coli
1
2009
831
0.050
Why?
Diagnosis, Differential
1
2009
1500
0.050
Why?
North America
1
2025
299
0.050
Why?
Half-Life
1
2004
157
0.050
Why?
Streptococcus pyogenes
1
2004
41
0.050
Why?
Amoxicillin-Potassium Clavulanate Combination
1
2024
16
0.050
Why?
Patient Discharge
2
2025
991
0.050
Why?
Acyclovir
1
2004
97
0.050
Why?
Child Development Disorders, Pervasive
1
2004
63
0.050
Why?
Hematologic Neoplasms
1
2006
169
0.050
Why?
Reproducibility of Results
2
2023
3396
0.050
Why?
Vomiting
1
2004
131
0.050
Why?
beta-Lactamases
1
2024
54
0.050
Why?
Kinetics
1
2007
1553
0.050
Why?
Sulbactam
1
2023
6
0.050
Why?
Stromal Cells
1
2023
123
0.050
Why?
Ampicillin
1
2023
17
0.050
Why?
Nasopharynx
1
2023
72
0.050
Why?
Haemophilus influenzae
1
2023
67
0.050
Why?
Pneumonia
1
2009
633
0.050
Why?
Multiplex Polymerase Chain Reaction
1
2023
56
0.050
Why?
Cephalothin
1
2022
5
0.050
Why?
Oxacillin
1
2022
5
0.050
Why?
Type C Phospholipases
1
2002
69
0.050
Why?
Methicillin
1
2022
10
0.050
Why?
Cefazolin
1
2022
22
0.050
Why?
Cornea
1
2023
156
0.040
Why?
Butanes
1
2021
3
0.040
Why?
Cell Extracts
1
2021
19
0.040
Why?
DNA Glycosylases
1
2021
10
0.040
Why?
Single-Cell Analysis
1
2025
366
0.040
Why?
Motivation
1
2026
601
0.040
Why?
Gestational Age
1
2025
989
0.040
Why?
Cell Communication
1
2023
327
0.040
Why?
Pyridinium Compounds
1
2021
31
0.040
Why?
Ubiquinone
1
2021
36
0.040
Why?
Autophagy-Related Proteins
1
2021
46
0.040
Why?
Developmental Disabilities
1
2004
280
0.040
Why?
Streptococcus pneumoniae
1
2023
187
0.040
Why?
Megakaryocytes
1
2021
34
0.040
Why?
Arkansas
1
2021
23
0.040
Why?
Reference Standards
1
2021
176
0.040
Why?
Microbiology
1
2021
24
0.040
Why?
Organophosphorus Compounds
1
2021
84
0.040
Why?
Pilot Projects
1
2026
1878
0.040
Why?
Staining and Labeling
1
2021
148
0.040
Why?
NLR Family, Pyrin Domain-Containing 3 Protein
1
2021
167
0.040
Why?
Seizures
1
2004
489
0.040
Why?
Drug Combinations
1
2021
399
0.040
Why?
Myositis
1
2020
57
0.040
Why?
Ubiquitin-Protein Ligases
1
2021
198
0.040
Why?
Randomized Controlled Trials as Topic
1
2026
1754
0.040
Why?
Coronary Vessels
1
2021
245
0.040
Why?
Pseudomonas aeruginosa
1
2002
392
0.040
Why?
Neoplasms
2
2025
2944
0.040
Why?
Diagnostic Errors
1
2020
178
0.040
Why?
Feces
2
2015
494
0.040
Why?
Clindamycin
1
2018
14
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2024
1429
0.030
Why?
Developed Countries
1
2018
38
0.030
Why?
Hospital Charges
1
2018
45
0.030
Why?
Cross-Sectional Studies
2
2021
5875
0.030
Why?
Bacteriological Techniques
1
2018
66
0.030
Why?
Methyltransferases
1
2018
73
0.030
Why?
Leukocytes, Mononuclear
1
2021
585
0.030
Why?
Research Design
1
2004
1139
0.030
Why?
Prostatic Neoplasms
1
2025
972
0.030
Why?
Medical Staff, Hospital
1
2018
80
0.030
Why?
Controlled Before-After Studies
1
2017
15
0.030
Why?
Metformin
1
2021
328
0.030
Why?
Age Distribution
1
2018
395
0.030
Why?
Sex Distribution
1
2018
379
0.030
Why?
Blood Platelets
1
2021
380
0.030
Why?
Epithelial Cells
1
2023
1118
0.030
Why?
Arthritis, Rheumatoid
1
2006
1184
0.030
Why?
Benchmarking
1
2018
192
0.030
Why?
Telemedicine
1
2026
956
0.030
Why?
Mice
2
2021
18266
0.030
Why?
Vaccination
1
2025
1444
0.030
Why?
Myocardium
1
2021
948
0.030
Why?
Comorbidity
1
2021
1652
0.030
Why?
Early Diagnosis
1
2016
249
0.030
Why?
Lung
1
2009
4119
0.030
Why?
Genomics
1
2021
851
0.030
Why?
Algorithms
1
2023
1843
0.030
Why?
Asthma
1
2006
1800
0.030
Why?
Recurrence
1
2017
1125
0.030
Why?
Alcoholism
1
2021
830
0.030
Why?
Inservice Training
1
2014
114
0.020
Why?
Kidney
1
2021
1491
0.020
Why?
Cell Differentiation
1
2021
1979
0.020
Why?
Polymorphism, Single Nucleotide
1
2021
2228
0.020
Why?
Substrate Specificity
2
2004
387
0.020
Why?
Medical Oncology
1
2015
344
0.020
Why?
Brain
1
2004
2981
0.020
Why?
Hypoglycemic Agents
1
2021
1411
0.020
Why?
Disease Models, Animal
1
2021
4565
0.020
Why?
Dysentery, Amebic
1
2008
2
0.020
Why?
Surveys and Questionnaires
1
2021
6050
0.020
Why?
Case-Control Studies
1
2015
3633
0.020
Why?
Polymerase Chain Reaction
1
2008
1030
0.010
Why?
Prophages
1
2004
8
0.010
Why?
Structure-Activity Relationship
1
2004
561
0.010
Why?
Postoperative Complications
1
2016
2962
0.010
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2002
143
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
2002
326
0.010
Why?
Choline
1
2002
134
0.010
Why?
Alleles
1
2004
900
0.010
Why?
Phospholipids
1
2002
215
0.010
Why?
Base Sequence
1
2004
2119
0.010
Why?
Hemolysis
1
2002
242
0.010
Why?
Calcium
1
2002
1181
0.010
Why?
Aged
1
2009
26251
0.000
Why?
Middle Aged
1
2009
36359
0.000
Why?
Parker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)